BioCentury | Oct 6, 2008
Clinical News

Platelet Pan Genera Detection regulatory update

...pathogenic bacteria, received 510(k) clearance in the U.S. last year (see BioCentury, Sept. 24, 2007). Verax Biomedical Inc....
BioCentury | Sep 24, 2007
Clinical News

Platelet Pan Genera Detection regulatory update

...FDA granted 510(k) clearance to Verax's Platelet Pan Genera Detection (PGD) test system to detect bacterial...
...exclusive marketing and distribution rights to the test last year (see BioCentury, Oct. 30, 2006). Verax Biomedical Inc....
BioCentury | May 14, 2007
Company News

Verax management update

Verax Biomedical Inc. , Worcester, Mass. Business: Diagnostic Hired: R. Scott McKenzie as SVP of operations, formerly site director at Abbott Laboratories ' Abbott Diagnostics immunoassay manufacturing unit; and Nancy Hornbaker as VP of regulatory affairs,...
BioCentury | Jan 29, 2007
Company News

Verax board of directors update

Verax Biomedical Inc. , Worchester, Mass. Business: Diagnostic Appointed: James Koziarz, former corporate VP of hepatitis/retrovirus research and development and assay technical support at Abbott Laboratories WIR Staff Diagnostic Hepatic Infectious...
BioCentury | Oct 30, 2006
Company News

Abbott, Verax sales and marketing update

...ABT received exclusive worldwide rights to market and distribute Verax's Verax Platelet PGD test to diagnose...
...immediately prior to transfusion. The test is based on Verax's Pan Genera Detection (PGD) technology. Verax...
...test by year end. Further terms were not disclosed. Abbott Laboratories (ABT), Abbott Park, Ill. Verax Biomedical Inc....
BioCentury | Oct 15, 2005
Financial News

Verax raises $15 million

...platelets immediately prior to transfusion. The test, which is in preclinical development, is based on Verax's...
BioCentury | Sep 1, 2003
Finance

Ebb & Flow

...which is developing combination therapies for diseases including cancer and rheumatoid arthritis; blood testing company Verax...
BioCentury | Aug 27, 2003
Financial News

BioVentures raises $54 million

...rheumatoid arthritis; Enanta (Watertown, Mass.), which is developing antibiotics and immunosuppressants; and blood testing company Verax...
BioCentury | Aug 2, 1993
Company News

Cellex sales and marketing update

...agreement under which ReceptorTechnologies Ltd. will marketing CLXX's Verax product line in England and Ireland. Verax...
BioCentury | Jun 28, 1993
Company News

Cellex Biosciences Inc sales and marketing update

...distribution agreement under which Tosoh Corp. of Tokyo will market Cellex's Verax products in Japan. Verax...
Items per page:
1 - 10 of 11
BioCentury | Oct 6, 2008
Clinical News

Platelet Pan Genera Detection regulatory update

...pathogenic bacteria, received 510(k) clearance in the U.S. last year (see BioCentury, Sept. 24, 2007). Verax Biomedical Inc....
BioCentury | Sep 24, 2007
Clinical News

Platelet Pan Genera Detection regulatory update

...FDA granted 510(k) clearance to Verax's Platelet Pan Genera Detection (PGD) test system to detect bacterial...
...exclusive marketing and distribution rights to the test last year (see BioCentury, Oct. 30, 2006). Verax Biomedical Inc....
BioCentury | May 14, 2007
Company News

Verax management update

Verax Biomedical Inc. , Worcester, Mass. Business: Diagnostic Hired: R. Scott McKenzie as SVP of operations, formerly site director at Abbott Laboratories ' Abbott Diagnostics immunoassay manufacturing unit; and Nancy Hornbaker as VP of regulatory affairs,...
BioCentury | Jan 29, 2007
Company News

Verax board of directors update

Verax Biomedical Inc. , Worchester, Mass. Business: Diagnostic Appointed: James Koziarz, former corporate VP of hepatitis/retrovirus research and development and assay technical support at Abbott Laboratories WIR Staff Diagnostic Hepatic Infectious...
BioCentury | Oct 30, 2006
Company News

Abbott, Verax sales and marketing update

...ABT received exclusive worldwide rights to market and distribute Verax's Verax Platelet PGD test to diagnose...
...immediately prior to transfusion. The test is based on Verax's Pan Genera Detection (PGD) technology. Verax...
...test by year end. Further terms were not disclosed. Abbott Laboratories (ABT), Abbott Park, Ill. Verax Biomedical Inc....
BioCentury | Oct 15, 2005
Financial News

Verax raises $15 million

...platelets immediately prior to transfusion. The test, which is in preclinical development, is based on Verax's...
BioCentury | Sep 1, 2003
Finance

Ebb & Flow

...which is developing combination therapies for diseases including cancer and rheumatoid arthritis; blood testing company Verax...
BioCentury | Aug 27, 2003
Financial News

BioVentures raises $54 million

...rheumatoid arthritis; Enanta (Watertown, Mass.), which is developing antibiotics and immunosuppressants; and blood testing company Verax...
BioCentury | Aug 2, 1993
Company News

Cellex sales and marketing update

...agreement under which ReceptorTechnologies Ltd. will marketing CLXX's Verax product line in England and Ireland. Verax...
BioCentury | Jun 28, 1993
Company News

Cellex Biosciences Inc sales and marketing update

...distribution agreement under which Tosoh Corp. of Tokyo will market Cellex's Verax products in Japan. Verax...
Items per page:
1 - 10 of 11